<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="197731">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00516776</url>
  </required_header>
  <id_info>
    <org_study_id>5.2007.910</org_study_id>
    <nct_id>NCT00516776</nct_id>
  </id_info>
  <brief_title>The Innate Immune System and Inflammatory Bowel Disease</brief_title>
  <official_title>The Innate Immune System and Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Royal Norwegian Ministry of Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study includes individuals with ulcerative colitis, Crohn's disease and healthy
      controls. The purpose of this study is to examine the innate immune system (IIS) by exposing
      peripheral blood monocytes to various ligands relevant for stimulation of the IIS and study
      the immune response. Colonic mucosal samples are examined to find gene expression patterns
      which may distinguish the two forms of disease from each other and from healthy controls.

      The hypothesis is that the innate immune system has responses unique for the disease states,
      and that the diseases may be differentiated by examination of gene expression patterns in
      mucosal biopsies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>gene expression patterns in mucosal biopsies</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Ulcerative Colitis</condition>
  <condition>Crohn's Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Intestinal biopsies Plasma/serum Peripheral blood monocytes
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from endoscopy unit and outpatients clinic with ulcerative colitis, Crohn's
        disease and healthy controls
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of ulcerative colitis

          -  Presence of Crohn's disease

          -  Healthy (no sign of inflammatory bowel disease)

        Exclusion Criteria:

          -  Anticoagulation

          -  Cardiac valvular disease

          -  Intravascular prosthesis

          -  Coagulation disorders

          -  Gastrointestinal malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arne K Sandvik, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Arne K Sandvik, MD PhD</last_name>
    <phone>+47 73598808</phone>
    <email>arne.sandvik@ntnu.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Helge L Waldum, MD PhD</last_name>
    <phone>+47 73868541</phone>
    <email>helge.waldum@ntnu.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept of Cancer Research and Molecular Medicine, NTNU</name>
      <address>
        <city>Trondheim</city>
        <zip>NO-7489</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 16, 2016</lastchanged_date>
  <firstreceived_date>August 14, 2007</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
